Capital Group Investment Management Pte. Ltd. Crispr Therapeutics Ag Transaction History
Capital Group Investment Management Pte. Ltd.
- $475 Million
- Q3 2024
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 27,116 shares of CRSP stock, worth $1.37 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
27,116
Previous 27,116
-0.0%
Holding current value
$1.37 Million
Previous $1.46 Million
12.98%
% of portfolio
0.27%
Previous 0.33%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
493Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$400 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$378 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$151 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$150 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$150 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.93B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....